We recently put the spotlight on Entrepreneurship in Arizona. Here, Pagely CEO Joshua Strebel shares another terrific story of bootstrapping success from Arizona. Sramana Mitra: Let’s start at the very beginning of your journey. Where are you from? Where were you born and raised? What kind of background? Joshua Strebel: I was born in a little town
Sramana Mitra: What you just said is very interesting from a computer science point of view. So far, it seems like pharma has been developing drugs with clinical trials that have relatively small numbers of people whose data is going into trial input. The big data opportunity is to do this at a much higher
David Lambert, Managing Director at Right Side Capital Management, a firm that invests small chunks of capital in capital efficient ventures. The firm is very much in line with the Bootstrapping to Exit philosophy we’ve been discussing.
Sramana Mitra: Before we move to the entrepreneurial discussions, could you talk a little bit about the three venture funds that have put Arka Ventures together. What do you envision would be their roles in follow-on financing in the companies that come into Arka? Yash Hemaraj: We wanted to make this an open and powerful
Today’s 437th FREE online 1Mby1M Roundtable For Entrepreneurs is starting NOW, on Thursday, March 28, at 8 a.m. PDT/11 a.m. EDT/4 p.m. CET/8:30 p.m. India IST. Click here to join. All are welcome!
Today’s 437th FREE online 1Mby1M Roundtable For Entrepreneurs is starting in 30 minutes, on Thursday, March 28, at 8 a.m. PDT/11 a.m. EDT/4 p.m. CET/8:30 p.m. India IST. Click here to join. All are welcome!
Sramana Mitra: You put in context what might happen with the existing workflow of the drug development as we introduce more capability from a scalability point of view. Instead of a drug going through three or four stages of clinical trials, maybe it will go through five or ten stages of clinical trials going into
Mark Selcow, General Partner at Costanoa Ventures, talks about the firm’s primarily B-to-B investment thesis and strong penchant for investing in companies that have grown up outside the Bay Area.